| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 201,852 | 183,196 | 128,012 | 137,274 | | Cost of Revenue | 148,730 | 135,280 | 97,339 | 97,915 | | | Gross Profit | 53,122 | 47,916 | 30,673 | 39,359 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 35,418 | 42,665 | 22,375 | 25,221 | | Non Recurring |
-
| (8,219) | 8,219 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,704 | 13,470 | 79 | 14,138 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 483 | 209 | 267 | 2,041 | | Earnings Before Interest And Taxes | 18,187 | 13,679 | 346 | 16,179 | | Interest Expense | 2,327 | 2,353 | 1,124 | 1,852 | | Income Before Tax | 15,860 | 11,326 | (778) | 14,327 | | Income Tax Expense | 4,939 | 3,156 | (411) | 3,783 | | Minority Interest | (1,003) |
-
|
-
| (199) | | | | Net Income From Continuing Ops | 10,929 | 8,178 | (682) | 10,342 | | | Non-recurring Events | | Discontinued Operations | (2,646) | (1,192) | (98) | (692) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,283 | 6,986 | (780) | 9,650 | | Preferred Stock And Other Adjustments | 864 | (439) | (425) |
-
| | | Net Income Applicable To Common Shares | $9,147 | $6,547 | ($1,205) | $9,650 |
|
0.51% Nasdaq 
0.14 (0.62%) 
Income Statement
